Pearl Diagnostics

Baltimore, MD · Founded 2014 · Privately Held (backing)

Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections. Pearl Diagnostics is based in Baltimore, MD and was founded in 2014. Its last reported valuation was $15 million in Jun 2022. It has raised $4.5 million across 2 recorded rounds; the latest was an $11.2 million early-stage round in Mar 2026.

Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
Early Stage VC
Mar 2026

Who backs Pearl Diagnostics?

11 investors
InvestorType
Creative Destruction LabOther
US National Science FoundationOther
TEDCOVenture capital
CARB-XOther
John Cammack—
John Wakeman—
Johns Hopkins Technology Ventures—
Joseph Callanan—
Roemer Capital—
Truttaceous—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pearl Diagnostics investors

11 investors are on record for Pearl Diagnostics, including Creative Destruction Lab, US National Science Foundation, TEDCO and CARB-X. The early-stage round in Mar 2026 drew 21 investors.

Free account
More of Pearl Diagnostics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Pearl Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Pearl Diagnostics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View